Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2.
Nakanuma S, Tajima H, Okamoto K, Hayashi H, Nakagawara H, Onishi I, Takamura H, Kitagawa H, Fushida S, Tani T, Fujimura T, Kayahara M, Ohta T, Wakayama T, Iseki S, Harada S. Nakanuma S, et al. Among authors: nakagawara h. Int J Oncol. 2010 Apr;36(4):793-800. doi: 10.3892/ijo_00000555. Int J Oncol. 2010. PMID: 20198321 Free article.
Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells.
Okamoto K, Tajima H, Ohta T, Nakanuma S, Hayashi H, Nakagawara H, Onishi I, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Tani T, Fujimura T, Kayahara M, Harada S, Wakayama T, Iseki S. Okamoto K, et al. Among authors: nakagawara h. Int J Oncol. 2010 Nov;37(5):1251-9. doi: 10.3892/ijo_00000776. Int J Oncol. 2010. PMID: 20878072
Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
Okamoto K, Tajima H, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Harada S, Wakayama T, Iseki S, Ohta T. Okamoto K, et al. Among authors: nakagawara h. Int J Oncol. 2012 Aug;41(2):573-82. doi: 10.3892/ijo.2012.1499. Epub 2012 May 29. Int J Oncol. 2012. PMID: 22664794 Free article.
Evaluation of eligibility criteria in living donor liver transplantation for hepatocellular carcinoma by α-SMA-positive cancer-associated fibroblasts.
Takamura H, Nakanuma S, Hayashi H, Tajima H, Kakinoki K, Sakai S, Makino I, Nakagawara H, Miyashita T, Okamoto K, Nakamura K, Oyama K, Inokuchi M, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Ohnishi I, Kayahara M, Tani T, Arai K, Yamashita T, Yamashita T, Kitamura H, Ikeda H, Kaneko S, Nakanuma Y, Matsui O, Ohta T. Takamura H, et al. Among authors: nakagawara h. Oncol Rep. 2013 Oct;30(4):1561-74. doi: 10.3892/or.2013.2616. Epub 2013 Jul 16. Oncol Rep. 2013. PMID: 23863893 Free PMC article.
Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation.
Mawatari T, Ninomiya I, Inokuchi M, Harada S, Hayashi H, Oyama K, Makino I, Nakagawara H, Miyashita T, Tajima H, Takamura H, Fushida S, Ohta T. Mawatari T, et al. Among authors: nakagawara h. Int J Oncol. 2015 Dec;47(6):2073-81. doi: 10.3892/ijo.2015.3213. Epub 2015 Oct 20. Int J Oncol. 2015. PMID: 26497673 Free PMC article.
Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.
Miyanaga S, Ninomiya I, Tsukada T, Okamoto K, Harada S, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara H, Miyashita T, Tajima H, Takamura H, Fushida S, Ohta T. Miyanaga S, et al. Among authors: nakagawara h. Int J Oncol. 2016 Feb;48(2):517-24. doi: 10.3892/ijo.2015.3291. Epub 2015 Dec 14. Int J Oncol. 2016. PMID: 26676807
135 results